Family History and Health Risk Assessment

Genomic and Personalized Medicine

Volumn , Issue , 2012, Pages 306-323

  Rubinstein, Wendy S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84905675458     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382227-7.00026-4     Document Type: Chapter

References (163)

1. Acheson L.S., Wang C., Zyzanski S.J., et al. Family history and perceptions about risk and prevention for chronic diseases in primary care: A report from the Family Healthware™ Impact Trial. Genet Med 2010, 12:212-218.
2. Acheson L.S., Wiesner G.L., Zyzanski S.J., Goodwin M.A., Stange K.C. Family history-taking in community family practice: Implications for genetic screening. Genet Med 2000, 2(3):180-185.
3. Adams, T.D. and Hunt, S.C. 2009. Perspectives on the Utility of Family History as a Screening Tool: The Utah State Experience. Available online at . http://consensus.nih.gov/2009/familyhistoryabstracts.htm#adams.
4. American Cancer Society Cancer facts and figures. [online] 2005. [cited 2005 August 17]. Am Cancer Soc 2005.
5. Amir E., Evans D.G., Shenton A., et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet. 2003, 40(11):807-814.
6. Anonymous, et al. Standards of medical care in diabetes--2008. Diabetes Care 2008, 31(Suppl. 1):S12-S54.
7. Antoniou A.C., Pharoah P.P., Smith P., Easton D.F. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 2004, 91(8):1580-1590.
8. Aston C.E., Ralph D.A., Lalo D.P., et al. Oligogenic combinations associated with breast cancer risk in women under 53 years of age. Hum Genet 2005, 116(3):208-221.
9. Bensen J.T., Liese A.D., Rushing J.T., et al. Accuracy of proband reported family history: The NHLBI Family Heart Study (FHS). Genet Epidemiol 1999, 17(2):141-150.
10. Berg A.O., Baird M.A., Botkin J.R., et al. National Institutes of Health State-of-the-Science Conference statement: Family history and improving health. Ann Intern Med 2009, 151(12):872-877.
11. Berg A.O., Baird M.A., Botkin J.R., et al. National Institutes of Health State-of-the-Science Conference statement: Family history and improving health, August 24-26, 2009. NIH Consens. State Sci Statements 2009, 26(1):1-19.
12. Biesecker L.G., Mullikin J.C., Facio F.M., et al. The ClinSeq Project: Piloting large-scale genome sequencing for research in genomic medicine. Genome Res 2009, 19(9):1665-1674.
13. Bjornholt J.V., Erikssen G., Liestol K., Jervell J., Thaulow E., Erikssen J. Type 2 diabetes and maternal family history: An impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men. Diabetes Care 2000, 23(9):1255-1259.
14. Broderick P., Wang Y., Vijayakrishnan J., et al. Deciphering the impact of common genetic variation on lung cancer risk: A genome-wide association study. Cancer Res 2009, 69(16):6633-6641.
15. Burke W., Daly M., Garber J., et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. JAMA 1997, 277(12):997-1003.
16. Butterworth A. Family History as a Risk Factor for Common, Complex Disease 2007, Public Health Genetics Unit [now the PHG Foundation], Available online at www.PHGFoundation.org.
17. Byrne J. Folic acid knowledge and use among relatives in Irish families with neural tube defects: An intervention study. Ir J Med Sci 2003, 172(3):118-122.
18. Califf R.M., Ginsburg G.S. Organizational improvements to enhance modern clinical epidemiology. JAMA 2008, 300(19):2300-2302.
19. Cerhan J.R., Parker A.S., Putnam S.D., et al. Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 1999, 8(1):53-60.
20. Cirulli E.T., Goldstein D.B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010, 11(6):415-425.
21. Claassen L., Henneman L., Janssens A.C., et al. Using family history information to promote healthy lifestyles and prevent diseases; A discussion of the evidence. BMC Public Health 2010, 10:248.
22. Cohn W.F., Ropka M.E., Pelletier S.L., et al. Health Heritage, a web-based tool for the collection and assessment of family health history: Initial user experience and analytic validity. Public Health Genomics 2010, 13:477-491.
23. De Jager P.L., Jia X., Wang J., et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009, 41(7):776-782.
24. Dolan S.M., Moore C. Linking family history in obstetric and pediatric care: Assessing risk for genetic disease and birth defects. Pediatrics 2007, 120(Suppl. 2):S66-S70.
25. Dolin R.H., Alschuler L., Boyer S., et al. HL7 clinical document architecture, release 2. J Am Med Inform Assoc 2006, 13(1):30-39.
26. Domchek S.M., Friebel T.M., Singer C., et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010, 304(9):967-975.
27. Downing G.J., Boyle S.N., Brinner K.M., Osheroff J.A. Information management to enable personalized medicine: Stakeholder roles in building clinical decision support. BMC Med Inform Decis Mak 2009, 8(9):44.
28. Drohan B., Ozanne E.M., Hughes K.S. Electronic health records and the management of women at high risk of hereditary breast and ovarian cancer. Breast J 2009, 15(Suppl. 1):S46-S55.
29. Emery J. Evaluation of questionnaire on cancer family history in general practice. Principal role of primary care is not to seek out those at increased genetic risk. BMJ 2000, 320(7228):186-187.
30. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497.
31. Facio F.M., Feero W.G., Linn A., Oden N., Manickam K., Biesecker L.G. Validation of My Family Health Portrait for six common heritable conditions. Genet Med 2010, 12(6):370-375.
32. Feero W.G., Bigley M.B., Brinner K.M. New standards and enhanced utility for family health history information in the electronic health record: An update from the American Health Information Community's Family Health History Multi-Stakeholder Workgroup. J Am Med Inform Assoc 2008, 15(6):723-728.
33. Frezzo T.M., Rubinstein W.S., Dunham D., Ormond K.E. The genetic family history as a risk assessment tool in internal medicine. Genet Med 2003, 5(2):84-91.
34. Fuchs C.S., Giovannucci E.L., Colditz G.A., Hunter D.J., Speizer F.E., Willett W.C. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994, 331(25):1669-1674.
35. Gail M.H., Brinton L.A., Byar D.P., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81(24):1879-1886.
36. Giles J.T., Kennedy D.T., Dunn E.C., Wallace W.L., Meadows S.L., Cafiero A.C. Results of a community pharmacy-based breast cancer risk-assessment and education program. Pharmacotherapy 2001, 21(2):243-253.
37. Ginsburg G.S., Willard H.F. Genomic and personalized medicine: Foundations and applications. Transl Res 2009, 154(6):277-287.
38. Goldgar D.E., Easton D.F., Deffenbaugh A.M., Monteiro A.N., Tavtigian S.V., Couch F.J. Integrated evaluation of DNA sequence variants of unknown clinical significance: Application to BRCA1 and BRCA2. Am J Hum Genet 2004, 75(4):535-544.
39. Goode E.L., Chenevix-Trench G., Song H., et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 2010, 42(10):874-879.
40. Gramling R., Nash J., Siren K., Eaton C., Culpepper L. Family physician self-efficacy with screening for inherited cancer risk. Ann Fam Med 2004, 2(2):130-132.
41. Green R.F. Summary of workgroup meeting on use of family history information in pediatric primary care and public health. Pediatrics 2007, 120(Suppl. 2):S87-100.
42. Guttmacher A.E., Collins F.S., Carmona R.H. The family history-more important than ever. N Engl J Med 2004, 351(22):2333-2336.
43. Hall R., Saukko P.M., Evans P.H., Qureshi N., Humphries S.E. Assessing family history of heart disease in primary care consultations: A qualitative study. Fam Pract 2007, 24(5):435-442.
44. Hariri S., Yoon P.W., Qureshi N., Valdez R., Scheuner M.T., Khoury M.J. Family history of type 2 diabetes: A population-based screening tool for prevention?. Genet Med 2006, 8(2):102-108.
45. Hay J.L., McCaul K.D., Magnan R.E. Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Prev Med 2006, 42(6):401-408.
46. Hayflick S.J., Eiff M.P., Carpenter L., Steinberger J. Primary care physicians' utilization and perceptions of genetics services. Genet Med 1998, 1(1):13-21.
47. Helzlsouer K.J., Ford D.E., Hayward R.S., Midzenski M., Perry H. Perceived risk of cancer and practice of cancer prevention behaviors among employees in an oncology center. Prev Med 1994, 23(3):302-308.
48. Hindorff L.A., Junkins H.A., Hall P.N., Mehta J.P., Manolio T.A. A Catalog of Published Genome-Wide Association Studies 2011, National Human Genome Research Institute, Available online at: www.genome.gov/gwastudies.
49. Hippisley-Cox J., Coupland C., Robson J., Sheikh A., Brindle P. Predicting risk of type 2 diabetes in England and Wales: Prospective derivation and validation of QDScore. BMJ 2009, 338:b880.
50. Holden D., Harris R., Porterfield D., et al. Enhancing the Use and Quality of Colorectal Cancer Screening. Evidence Report/Technology Assessment No.190, AHRQ Publication 10-E-002 2010, Agency for Healthcare Research and Quality.
51. Houlston R.S., Cheadle J., Dobbins S.E., et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet 2010, 42(11):973-977.
52. Ikram M.A., Seshadri S., Bis J.C., et al. Genome-wide association studies of stroke. N. Engl. J Med 2009, 360(17):1718-1728.
53. Isaacs C., Peshkin B.N., Schwartz M., DeMarco T.A., Main D., Lerman C. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat 2002, 71(2):103-112.
54. Janssens A.C., Gwinn M., Bradley L.A., Oostra B.A., van Duijn C.M., Khoury M.J. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 2008, 82(3):593-599.
55. Johnson J., Giles R.T., Larsen L., Ware J., Adams T., Hunt S.C. Utah's Family High Risk Program: Bridging the gap between genomics and public health. Prev Chronic Dis 2005, 2(2):A24.
56. Jood K., Ladenvall C., Rosengren A., Blomstrand C., Jern C. Family history in ischemic stroke before 70 years of age: The Sahlgrenska academy study on ischemic stroke. Stroke 2005, 36(7):1383-1387.
57. Kadison P., Pelletier E.M., Mounib E.L., Oppedisano P., Poteat H.T. Improved screening for breast cancer associated with a telephone-based risk assessment. Prev Med 1998, 27(3):493-501.
58. Kahn L.B., Marshall J.A., Baxter J., Shetterly S.M., Hamman R.F. Accuracy of reported family history of diabetes mellitus. Results from San Luis valley diabetes study. Diabetes Care 1990, 13(7):796-798.
59. Kawamoto K., Houlihan C.A., Balas E.A., Lobach D.F. Improving clinical practice using clinical decision support systems: A systematic review of trials to identify features critical to success. BMJ 2005, 330(7494):765.
60. Kawamoto K., Lobach D.F., Willard H.F., Ginsburg G.S. A national clinical decision support infrastructure to enable the widespread and consistent practice of genomic and personalized medicine. BMC Med Inform. Decis Mak 2009, 9:17.
61. Kee F., Tiret L., Robo J.Y., et al. Reliability of reported family history of myocardial infarction. BMJ 1993, 307(6918):1528-1530.
62. Kerber R.A., Slattery M.L. Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 1997, 146(3):244-248.
63. Khaw K.T., Barrett-Connor E. Family history of heart attack: A modifiable risk factor?. Circulation 1986, 74(2):239-244.
64. Khoury M.J., Bowen S., Bradley L.A., et al. A decade of public health genomics in the United States: Centers for Disease Control and Prevention 1997-2007. Public Health Genomics 2008, 12(1):20-29.
65. Khoury M.J., Feero W.G., Valdez R. Family history and personal genomics as tools for improving health in an era of evidence-based medicine. Am J Prev Med 2010, 39(2):184-188.
66. Khoury M.J., Gwinn M., Yoon P.W., Dowling N., Moore C.A., Bradley L. The continuum of translation research in genomic medicine: How can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?. Genet. Med 2007, 9(10):665-674.
67. Khoury M.J., McBride C.M., Schully S.D., et al. The scientific foundation for personal genomics: Recommendations from a national institutes of health-centers for disease control and prevention multidisciplinary workshop. Genet Med 2009, 11(8):559-567.
68. Khoury M.J., Rich E.C., Randhawa G., Teutsch S.M., Niederhuber J. Comparative effectiveness research and genomic medicine: An evolving partnership for 21st century medicine. Genet Med 2009, 11(10):707-711.
69. Kinzie M.B., Cohn W.F., Julian M.F., Knaus W.A. A user-centered model for web site design: Needs assessment, user interface design, and rapid prototyping. J Am Med Inform Assoc 2002, 9(4):320-330.
70. Klein B.E., Klein R., Moss S.E., Cruickshanks K.J. Parental history of diabetes in a population-based study. Diabetes Care 1996, 19(8):827-830.
71. Komenaka I.K., Ditkoff B.A., Joseph K.A., et al. The development of interval breast malignancies in patients with BRCA mutations. Cancer 2004, 100(10):2079-2083.
72. Kreuter M.W., Lukwago S.N., Bucholtz R.D., Clark E.M., Sanders-Thompson V. Achieving cultural appropriateness in health promotion programs: Targeted and tailored approaches. Health Educ Behav 2003, 30(2):133-146.
73. Kreuter M.W., Strecher V.J., Glassman B. One size does not fit all: The case for tailoring print materials. Ann Behav Med 1999, 21(4):276-283.
74. LaRusse S., Roberts J.S., Marteau T.M., et al. Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease. Genet Med 2005, 7(1):48-53.
75. Leventhal H., Brissette I., Leventhal E.A. The common-sense model of self-regulation of health and illness. The Self-Regulation of Health and Illness Behavior 2003, 42-65. Routledge, NY. L.D. Cameron, H. Leventhal (Eds.).
76. Liu T., Valdez R., Yoon P.W., Crocker D., Moonesinghe R., Khoury M.J. The association between family history of asthma and the prevalence of asthma among US adults: National Health and Nutrition Examination Survey, 1999-2004. Genet Med 2009, 11(5):323-328.
77. Lyssenko V., Jonsson A., Almgren P., et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008, 359(21):2220-2232.
78. Manolio T.A., Collins F.S., Cox N.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461(7265):747-753.
79. Mardis E.R. Anticipating the 1,000 dollar genome. Genome Biol 2006, 7(7):112.
80. McBride, C.M. Research challenge in affecting behavior change with family history information: Patients and providers.
81. McBride C.M., Bowen D., Brody L.C., et al. Future health applications of genomics: Priorities for communication, behavioral, and social sciences research. Am J Prev Med 2010, 38(5):556-565.
82. McBride C.M., Koehly L.M., Sanderson S.C., Kaphingst K.A. The behavioral response to personalized genetic information: Will genetic risk profiles motivate individuals and families to choose more healthful behaviors?. Annu Rev Public Health 2010, 31:89-103.
83. McGrath B.B., Edwards K.L. When family means more (or less) than genetics: The intersection of culture, family and genomics. J Transcult Nurs 2009, 20(3):270-277.
84. Michie S., Fixsen D., Grimshaw J.M., Eccles M.P. Specifying and reporting complex behaviour change interventions: The need for a scientific method. Implement. Sci 2009, 4:40. http://www.implementationscience.com/content/4/1/40.
85. Mitchell R.J., Brewster D., Campbell H., et al. Accuracy of reporting of family history of colorectal cancer. Gut 2004, 53(2):291-295.
86. Monzon J.G., Cremin C., Armstrong L., et al. Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer. Int J Cancer 2010, 126(4):930-939.
87. National Cancer Institute Genetics of Breast and Ovarian Cancer [Health Professional Version, online] September 30, 2004, National Cancer Institute, [cited 2004 November 1]. Available online at http://www.cancer.gov/cancertopics/pdq/genetics/breast-and-ovarian/healthprofessional.
88. National Comprehensive Cancer Network. National Comprehensive Cancer Network Clinical Guidelines in Oncology: Breast Cancer Screening and Diagnosis [online]. 2004a. [cited 2004 September 10]. Available online at . http://www.nccn.org/professionals/physician_gls/PDF/breast-screening.pdf.
89. National Comprehensive Cancer Network. National Comprehensive Cancer Network Clinical Guidelines in Oncology: Genetics/Familial High Risk Assessment. [online]. 2004b. [cited 2004 September 10]. Available online at . http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf.
90. Ng P.C., Murray S.S., Levy S., Venter J.C. An agenda for personalized medicine. Nature 2009, 461(7265):724-726.
91. Offit K. Genomic profiles for disease risk: Predictive or premature?. JAMA 2008, 299(11):1353-1355.
92. Olney R.S., Yoon P.W. Role of family medical history information in pediatric primary care and public health: Introduction. Pediatrics 2007, 120(Suppl. 2):S57-S59.
93. O'Neill S.M., Rubinstein W.S., Wang C., et al. Familial risk for common diseases in primary care: The Family Healthware™ Impact Trial. Am J Prev Med 2009, 36(6):506-514.
94. O'Neill S.M., Starzyk E., Kattezham R.A., Rubinstein W.S. Comparison of Family Healthware and physicians' family history documentation among 1124 patients. American Society of Human Genetics 2008, (Abstract #180).
95. Osheroff J.A., Teich J.M., Middleton B., Steen E.B., Wright A., Detmer D.E. A roadmap for national action on clinical decision support. J Am. Med Inform Assoc 2007, 14(2):141-145.
96. Ozanne E.M., Loberg A., Hughes S., et al. Identification and management of women at high risk for hereditary breast/ovarian cancer syndrome. Breast J 2009, 15(2):155-162.
97. Paynter N.P., Chasman D.I., Buring J.E., Shiffman D., Cook N.R., Ridker P.M. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med 2009, 150(2):65-72.
98. Petersen L., Nielsen G.G., Andersen P.K., Sorensen T.I. Case-control study of genetic and environmental influences on premature death of adult adoptees. Genet Epidemiol 2002, 23(2):123-132.
99. Pharoah P.D., Antoniou A.C., Easton D.F., Ponder B.A. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 2008, 358(26):2796-2803.
100. Pharoah P.D., Day N.E., Duffy S., Easton D.F., Ponder B.A. Family history and the risk of breast cancer: A systematic review and meta-analysis. Int J Cancer 1997, 71(5):800-809.
101. Pijl M., Timmermans D.R., Claassen L., et al. Impact of communicating familial risk of diabetes on illness perceptions and self-reported behavioral outcomes: A randomized controlled trial. Diabetes Care 2009, 32(4):597-599.
102. Qureshi N., Carroll J.C., Wilson B., et al. The current state of cancer family history collection tools in primary care: A systematic review. Genet Med 2009, 11(7):495-506.
103. Qureshi N., Kai J. Informing patients of familial diabetes mellitus risk: How do they respond? A cross-sectional survey. BMC Health Serv Res 2008, 8(1):37.
104. Qureshi N., Wilson B., Santaguida P., et al. Collection and Use of Cancer Family History in Primary Care 2007, Agency for Healthcare Research and Quality, Rockville, MD, AHRQ Publication 08-E001.
105. Qureshi N., Wilson B., Santaguida P., et al. Family history and improving health. Evid Rep Technol Assess (Full Rep) 2009, 186:1-135.
106. Ramsey S.D., Clarke L., Etzioni R., Higashi M., Berry K., Urban N. Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 2001, 135(8):577-588.
107. Reid G.T., Walter F.M., Brisbane J.M., Emery J.D. Family history questionnaires designed for clinical use: A systematic review. Public Health Genomics 2009, 12(2):73-83.
108. Rex D.K., Johnson D.A., Lieberman D.A., Burt R.W., Sonnenberg A. Colorectal cancer prevention 2000: Screening recommendations of the American college of gastroenterology. Am J Gastroenterol 2000, 95(4):868-877.
109. Rich E.C., Burke W., Heaton C.J., et al. Reconsidering the family history in primary care. J Gen Intern Med 2004, 19(3):273-280.
110. Ridker P.M., Buring J.E., Rifai N., Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score. JAMA 2007, 297(6):611-619.
111. Ridker P.M., Paynter N.P., Rifai N., Gaziano J.M., Cook N.R. C-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds risk score for men. Circulation 2008, 118(22):2243-2251.
112. Robitaille J., Yoon P.W., Moore C.A., et al. Prevalence, family history, and prevention of reported osteoporosis in U.S. women. Am J Prev Med 2008, 35(1):47-54.
113. Rubinstein W.S., O'Neill S.M. Quantitative risk assessment. Advanced Therapy of Breast Disease 2004, 97-112. BC Decker, Inc, Hamilton/London. second ed. S. Singletary, G.L. Robb, G. Hortobagyi (Eds.).
114. Rubinstein W.S., O'Neill, S.M., Ruffin M.T., and Acheson L.S., 2009. Perspectives on the utility of family history as a screening tool: The CDC family healthware experience. Available online at . http://consensus.nih.gov/2009/familyhistory.htm.
115. Rubinstein W.S., O'Neill S.M., Rothrock N., et al. Components of family history associated with women's disease perceptions for cancer: A report from the Family Healthware Impact Trial. Genet Med 2011, 13(1):52-62.
116. Rubinstein W.S., Acheson L.S., O'Neill S.M., et al. Clinical utility of family history for cancer screening and referral in primary care: A report from the Family Healthware Impact Trial. Genet Med 2011, 13(11):956-965.
117. Ruffin M.T., Nease D., Sen A., et al. Effect of preventive messages tailored to family history on health behaviors: The family healthware impact trial. Ann Fam Med 2010, 9(1):3-11.
118. Runeson B., Asberg M. Family history of suicide among suicide victims. Am J Psychiatry 2003, 160(8):1525-1526.
119. Salminen M., Vahlberg T., Kivela S.L. Effects of family-oriented risk-based prevention on serum cholesterol and blood pressure values of children and adolescents. Scand J Prim Health Care 2005, 23(1):34-41.
120. Salminen M., Vahlberg T., Ojanlatva A., Kivela S.L. Effects of a controlled family-based health education/counseling intervention. Am J Health Behav 2005, 29(5):395-406.
121. Sandhu M.S., Luben R., Khaw K.T. Prevalence and family history of colorectal cancer: Implications for screening. J Med Screen 2001, 8(2):69-72.
122. Scheuner M.T., Setodji C.M., Pankow J.S., Blumenthal R.S., Keeler E. General cardiovascular risk profile identifies advanced coronary artery calcium and is improved by family history: The multiethnic study of atherosclerosis. Circ Cardiovasc Genet 2010, 3(1):97-105.
123. Scheuner M.T., Sieverding P., Shekelle P.G. Delivery of genomic medicine for common chronic adult diseases: A systematic review. JAMA 2008, 299(11):1320-1334.
124. Scheuner M.T., Wang S.J., Raffel L.J., Larabell S.K., Rotter J.I. Family history: A comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet 1997, 71(3):315-324.
125. Scheuner M.T., Whitworth W.C., McGruder H., Yoon P.W., Khoury M.J. Expanding the definition of a positive family history for early-onset coronary heart disease. Genet Med 2006, 8(8):491-501.
126. Scheuner M.T., Whitworth W.C., McGruder H., Yoon P.W., Khoury M.J. Familial risk assessment for early-onset coronary heart disease. Genet Med 2006, 8(8):525-531.
127. Schumacher F.R., Berndt S.I., Siddiq A., et al. Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet 2011, 20(19):3867-3875.
128. Shah M., Zhu K., Palmer R.C., Jatoi I., Shriver C., Wu H. Breast, colorectal, and skin cancer screening practices and family history of cancer in U.S. women. J Womens Health (Larchmt.) 2007, 16(4):526-534.
129. Simon C., Acheson L., Burant C., et al. Patient interest in recording family histories of cancer via the Internet. Genet Med 2008, 10(12):895-902.
130. Sorensen T.I., Nielsen G.G., Andersen P.K., Teasdale T.W. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988, 318(12):727-732.
131. Steinberg G.D., Carter B.S., Beaty T.H., Childs B., Walsh P.C. Family history and the risk of prostate cancer. Prostate 1990, 17(4):337-347.
132. Stratton J.F., Pharoah P., Smith S.K., Easton D., Ponder B.A. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 1998, 105(5):493-499.
133. Suther S., Goodson P. Barriers to the provision of genetic services by primary care physicians: A systematic review of the literature. Genet Med 2003, 5(2):70-76.
134. Sweet K.M., Bradley T.L., Westman J.A. Identification and referral of families at high risk for cancer susceptibility. J Clin Oncol 2002, 20(2):528-537.
135. Tarini B.A., Singer D., Clark S.J., Davis M.M. Parents' concern about their own and their children's genetic disease risk: Potential effects of family history vs genetic test results. Arch Pediatr Adolesc Med 2008, 162(11):1079-1083.
136. Turnbull C., Ahmed S., Morrison J., et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010, 42(6):504-507.
137. Tyrer J., Duffy S.W., Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004, 23(7):1111-1130.
138. Valdez R., Greenlund K.J., Khoury M.J., Yoon P.W. Is family history a useful tool for detecting children at risk for diabetes and cardiovascular diseases? A public health perspective. Pediatrics 2007, 120(Suppl. 2):S78-S86.
139. Valdez R., Yoon P.W., Liu T., Khoury M.J. Family history and prevalence of diabetes in the US population: 6-year results from the National Health and Nutrition Examination Survey (NHANES, 1999-2004). Diabetes 2007 Jul 31 2007.
140. Valdez R., Yoon P.W., Qureshi N., Green R.F., Khoury M.J. Family history in public health practice: A genomic tool for disease prevention and health promotion. Annu Rev Public Health 2010, 31:69-87.
141. Volk L.A., Staroselsky M., Newmark L.P., et al. Do physicians take action on high risk family history information provided by patients outside of a clinic visit?. Stud. Health Technol Inform 2007, 129(1):13-17.
142. Walsh J.M., Terdiman J.P. Colorectal cancer screening: Clinical applications. JAMA 2003, 289(10):1297-1302.
143. Walsh T., Lee M.K., Casadei S., et al. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci USA 2010, 28(107):12,629-12,633.
144. Walter F.M., Emery J. Coming down the line'-patients' understanding of their family history of common chronic disease. Ann Fam Med 2005, 3(5):405-414.
145. Walter F.M., Emery J. Perceptions of family history across common diseases: A qualitative study in primary care. Fam Pract 2006, 23(4):472-480.
146. Walter F.M., Emery J., Braithwaite D., Marteau T.M. Lay understanding of familial risk of common chronic diseases: A systematic review and synthesis of qualitative research. Ann Fam Med 2004, 2(6):583-594.
147. Wang C., O'Neill S.M., Rothrock N., et al. Comparison of risk perceptions and beliefs across common chronic diseases. Prev Med 2009, 48(2):197-202.
148. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004, 292(11):1317-1325.
149. Watson P., Narod S.A., Fodde R., et al. Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer. J Med Genet 2003, 40(8):591-596.
150. Weinstein N.D. Unrealistic optimism about future life events. J Pers Soc Psychol 1980, 39(5):806-820.
151. Weinstein N.D. Unrealistic optimism about susceptibility to health problems. J Behav Med 1982, 5(4):441-460.
152. Westman J., Hampel H., Bradley T. Efficacy of a touchscreen computer-based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet 2000, 37(5):354-360.
153. Wiklund F., Zheng S.L., Sun J., et al. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Prostate 2009, 69(4):419-427.
154. Williams R.R., Hunt S.C., Heiss G., et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol 2001, 87(2):129-135.
155. Wilson B.J., Qureshi N., Santaguida P., et al. Systematic review: Family history in risk assessment for common diseases. Ann Intern Med 2009, 151(12):878-885.
156. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003, 124(2):544-560.
157. Xu J., Sun J., Kader A.K., et al. Estimation of absolute risk for prostate cancer using genetic markers and family history. Prostate 2009, 69(14):1565-1572.
158. Yang Q., Liu T., Valdez R., Moonesinghe R., Khoury M.J. Improvements in ability to detect undiagnosed diabetes by using information on family history among adults in the United States. Am J Epidemiol 2010, 171(10):1079-1089.
159. Yoon P.W., Scheuner M.T., Jorgensen C., Khoury M.J. Developing family healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis 2009, 6(1):A33.
160. Yoon P.W., Scheuner M.T., Khoury M.J. Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 2003, 24(2):128-135.
161. Yoon P.W., Scheuner M.T., Peterson-Oehlke K.L., Gwinn M., Faucett A., Khoury M.J. Can family history be used as a tool for public health and preventive medicine?. Genet Med 2002, 4(4):304-310.
162. Zheng S.L., Sun J., Wiklund F., et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008, 358(9):910-919.
163. Ziogas A., Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med 2003, 24(2):190-198.